During a live event, Hans Lee, MD, and participants discussed potential approaches to modifying frontline multiple myeloma ...

Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T-cell engagers, ...

New FDA approvals in July include therapies for NSCLC, relapsed multiple myeloma, liver cancer, and B-cell malignancies.

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s prostate cancer was recently labelled “aggressive” and described as having ...

Medically reviewed by Gagandeep Brar, MD The first sign of multiple myeloma differs for each person with the disease. Since this blood cancer tends to progress silently and slowly, many people do not ...

Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help ...

Johnson & Johnson (NYSE:JNJ) announced Wednesday that the European Commission has granted approval for its Darzalex ...

Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous ...

GSK’s Blenrep (belantamab mafodotin) combinations have been approved by the European Commission (EC) to treat adults with relapsed or refractory multiple myeloma.